DK2848254T3 - PYRAZOLD DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES - Google Patents
PYRAZOLD DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES Download PDFInfo
- Publication number
- DK2848254T3 DK2848254T3 DK13787714.8T DK13787714T DK2848254T3 DK 2848254 T3 DK2848254 T3 DK 2848254T3 DK 13787714 T DK13787714 T DK 13787714T DK 2848254 T3 DK2848254 T3 DK 2848254T3
- Authority
- DK
- Denmark
- Prior art keywords
- constipation
- compound
- administration
- week
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012105847 | 2012-05-07 | ||
PCT/JP2013/062755 WO2013168671A1 (ja) | 2012-05-07 | 2013-05-02 | ピラゾール誘導体及びその医薬用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2848254T3 true DK2848254T3 (en) | 2016-10-31 |
Family
ID=49550709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13787714.8T DK2848254T3 (en) | 2012-05-07 | 2013-05-02 | PYRAZOLD DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES |
Country Status (16)
Country | Link |
---|---|
US (2) | US9273085B2 (es) |
EP (1) | EP2848254B1 (es) |
JP (2) | JP5663699B2 (es) |
KR (1) | KR101868991B1 (es) |
CN (1) | CN104284665B (es) |
AU (1) | AU2013258566B2 (es) |
BR (1) | BR112014027841B1 (es) |
CA (1) | CA2872002C (es) |
DK (1) | DK2848254T3 (es) |
ES (1) | ES2601127T3 (es) |
HK (1) | HK1204773A1 (es) |
MX (1) | MX359988B (es) |
PL (1) | PL2848254T3 (es) |
PT (1) | PT2848254T (es) |
RU (1) | RU2602739C2 (es) |
WO (1) | WO2013168671A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2591188C2 (ru) | 2010-11-08 | 2016-07-10 | Альбирео Аб | Ингибиторы ibat для лечения заболеваний печени |
BR112014027841B1 (pt) * | 2012-05-07 | 2022-08-09 | Kissei Pharmaceutical Co., Ltd | Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação |
MX346453B (es) | 2013-02-04 | 2017-03-17 | Taisho Pharmaceutical Co Ltd | Medicamento profilactico o terapeutico para el estreñimiento. |
CA2952405A1 (en) * | 2014-06-25 | 2015-12-30 | Ea Pharma Co., Ltd. | Solid formulation and method for stabilizing the same |
CA2952406A1 (en) | 2014-06-25 | 2015-12-30 | Ea Pharma Co., Ltd. | Solid formulation and method for preventing or reducing coloration thereof |
CN112469407A (zh) | 2018-03-28 | 2021-03-09 | 阿沃林特有限公司 | 用于治疗餐后低血糖症的方法 |
EP3802504B1 (en) | 2018-06-05 | 2023-01-18 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11802115B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
JP2023504644A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
JP2023504647A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
IL293379A (en) | 2019-12-04 | 2022-07-01 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
CA3186857A1 (en) | 2020-08-03 | 2022-02-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
CN116583504A (zh) | 2020-12-04 | 2023-08-11 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
TW200801012A (en) * | 2006-04-26 | 2008-01-01 | Piramed Ltd | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
CN101910189B (zh) * | 2007-12-27 | 2013-06-19 | 橘生药品工业株式会社 | 吡唑衍生物的单癸二酸盐 |
ES2385185T3 (es) | 2008-04-16 | 2012-07-19 | Kissei Pharmaceutical Co., Ltd. | Hemifumarato de un derivado de pirazol |
AR087701A1 (es) | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
BR112014027841B1 (pt) * | 2012-05-07 | 2022-08-09 | Kissei Pharmaceutical Co., Ltd | Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação |
-
2013
- 2013-05-02 BR BR112014027841-5A patent/BR112014027841B1/pt active IP Right Grant
- 2013-05-02 AU AU2013258566A patent/AU2013258566B2/en active Active
- 2013-05-02 KR KR1020147033887A patent/KR101868991B1/ko active IP Right Grant
- 2013-05-02 EP EP13787714.8A patent/EP2848254B1/en active Active
- 2013-05-02 MX MX2014013696A patent/MX359988B/es active IP Right Grant
- 2013-05-02 CN CN201380024202.3A patent/CN104284665B/zh active Active
- 2013-05-02 ES ES13787714.8T patent/ES2601127T3/es active Active
- 2013-05-02 JP JP2014514708A patent/JP5663699B2/ja active Active
- 2013-05-02 PT PT137877148T patent/PT2848254T/pt unknown
- 2013-05-02 PL PL13787714T patent/PL2848254T3/pl unknown
- 2013-05-02 RU RU2014149181/15A patent/RU2602739C2/ru active
- 2013-05-02 DK DK13787714.8T patent/DK2848254T3/en active
- 2013-05-02 WO PCT/JP2013/062755 patent/WO2013168671A1/ja active Application Filing
- 2013-05-02 CA CA2872002A patent/CA2872002C/en active Active
- 2013-05-02 US US14/399,093 patent/US9273085B2/en active Active
-
2014
- 2014-12-04 JP JP2014245645A patent/JP6105546B2/ja active Active
-
2015
- 2015-06-05 HK HK15105374.8A patent/HK1204773A1/xx unknown
-
2016
- 2016-01-14 US US14/995,489 patent/US9694027B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2848254A4 (en) | 2015-07-15 |
KR101868991B1 (ko) | 2018-06-19 |
MX359988B (es) | 2018-10-18 |
CN104284665A (zh) | 2015-01-14 |
BR112014027841A2 (pt) | 2017-06-27 |
EP2848254B1 (en) | 2016-08-03 |
US9273085B2 (en) | 2016-03-01 |
US9694027B2 (en) | 2017-07-04 |
PL2848254T3 (pl) | 2017-03-31 |
EP2848254A1 (en) | 2015-03-18 |
RU2602739C2 (ru) | 2016-11-20 |
BR112014027841B1 (pt) | 2022-08-09 |
WO2013168671A1 (ja) | 2013-11-14 |
CA2872002A1 (en) | 2013-11-14 |
JP2015083580A (ja) | 2015-04-30 |
BR112014027841A8 (pt) | 2021-09-28 |
HK1204773A1 (en) | 2015-12-04 |
AU2013258566A1 (en) | 2014-11-27 |
AU2013258566B2 (en) | 2017-03-16 |
KR20150013671A (ko) | 2015-02-05 |
MX2014013696A (es) | 2015-02-05 |
PT2848254T (pt) | 2016-10-05 |
JP6105546B2 (ja) | 2017-03-29 |
US20160129031A1 (en) | 2016-05-12 |
JP5663699B2 (ja) | 2015-02-04 |
US20150141631A1 (en) | 2015-05-21 |
CN104284665B (zh) | 2016-11-16 |
JPWO2013168671A1 (ja) | 2016-01-07 |
ES2601127T3 (es) | 2017-02-14 |
RU2014149181A (ru) | 2016-06-27 |
CA2872002C (en) | 2019-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2848254T3 (en) | PYRAZOLD DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES | |
JP7312169B2 (ja) | 遺伝性てんかん性障害の処置に使用するガナキソロン | |
CN103338768B (zh) | 胃和结肠的配制剂及其制备和使用方法 | |
US20040092511A1 (en) | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders | |
JP2011157372A (ja) | 機能性腸障害を処置する方法 | |
CN114929209A (zh) | 肌萎缩侧索硬化的治疗 | |
JP6473254B2 (ja) | 下痢を治療するための製品及び方法 | |
US11834445B2 (en) | Polymorphic forms of metopimazine | |
US20160279166A1 (en) | Treating agent and treating method for the examination or operation of the large intestine | |
US20200038413A1 (en) | Methods of treating parkinson's disease using aminosterol compositions | |
TWI659739B (zh) | 便秘症之預防或治療藥 | |
CN102869645A (zh) | 用于治疗肠易激综合征的方法和组合物 | |
US20200038414A1 (en) | Methods of treating constipation using aminosterol compositions | |
US20200038417A1 (en) | Methods and compositions for treating cognitive impairment | |
CA3137019A1 (en) | New medical use | |
US20110269792A1 (en) | Compositions useful for treating irritable bowel syndrome |